One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
The Corporatization of U.S. Health Care: A Gilded Age for Patients? The Broken Promises of Profit-Driven Medicine
doi : 10.1056/NEJMp2415751
Volume 393 No. 6 August 7, 2025
Lead Contamination in Milwaukee Schools — The Latest Episode in an Ongoing Toxic Pandemic
doi : 10.1056/NEJMp2506801
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
doi : 10.1056/NEJMoa2410659
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
doi : 10.1056/NEJMoa2505725
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
doi : 10.1056/NEJMoa2502929
Combination Therapy for Chronic Kidney Disease and Type 2 Diabetes — A Promising Prelude
doi : 10.1056/NEJMe2508784
Science behind the Study: Degradation of the Estrogen Receptor in Breast Cancer
doi : 10.1056/NEJMe2507193
Restoring the Infant Mortality Rate as a Measure of Societal Health and Well-Being
doi : 10.1056/NEJMms2415762
Xenon — Propelling Climbers to the Summits of the World’s Highest Mountains?
doi : 10.1056/NEJMc2507671
